ANTIBODIES TO BOTULINUM NEUROTOXINS
The present disclosure provides antibodies that specifically bind to botulinum neurotoxins. The antibodies can be used in methods to specifically bind and, in some embodiments, neutralize, botulinum neurotoxin and are therefore also useful in the treatment of pathologies associated with botulinum neurotoxin poisoning..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 19. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
MARKS JAMES D [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-19, Last update posted on www.tib.eu: 2023-11-23, Last updated: 2023-12-01 |
|---|
| Patentnummer: |
WO2023201192 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018349404 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018349404 | ||
| 003 | DE-627 | ||
| 005 | 20231201100729.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231103s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018349404 | ||
| 035 | |a (EPA)WO2023201192 | ||
| 035 | |a (EPA)88330293 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a MARKS JAMES D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ANTIBODIES TO BOTULINUM NEUROTOXINS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-19, Last update posted on www.tib.eu: 2023-11-23, Last updated: 2023-12-01 | ||
| 520 | |a The present disclosure provides antibodies that specifically bind to botulinum neurotoxins. The antibodies can be used in methods to specifically bind and, in some embodiments, neutralize, botulinum neurotoxin and are therefore also useful in the treatment of pathologies associated with botulinum neurotoxin poisoning. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LOU JIANLONG |4 aut | |
| 700 | 0 | |a FAN YONGFENG |4 aut | |
| 700 | 0 | |a YAN SHUDE |4 aut | |
| 700 | 0 | |a RODRIGUEZ MARIA CONSUELO GARCIA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 19. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/88330293/publication/WO2023201192A1?q=WO2023201192 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 19 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 10 | ||